# Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)

> **NCT02088762** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 325 (actual)

## Conditions studied

- Melanoma

## Interventions

- **PROCEDURE:** surgical excision

## Key facts

- **NCT ID:** NCT02088762
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1997-01
- **Primary completion:** 2012-12
- **Final completion:** 2014-12
- **Target enrollment:** 325 (ACTUAL)
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02088762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02088762, "Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02088762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*